micro8.org
Forgot your password?
https://micro8.org/account/password/new
This site is intended for US Residents only. Please, enter the cell number or the email linked to your account. Instructions will be sent to your email. Biogen, the maker of ELOCTATE, has joined forces with MicroHealth —. An innovative community exclusively for people with Hemophilia A. Can help you connect to your care team, family and friends — even the rest of the Hemophilia A community — and share relevant information. You get the tools you need to help manage your Hemophilia. on your time. Allergic ...
micro8.org
Learn more about Micro8
https://micro8.org/pages/learn-more
This site is intended for US Residents only. Micro8 is a tool to help patients and their care team work together on their Hemophilia management plan. Patients and caregivers have 3 interactive ways to track their Hemophilia management plan and to receive infusion reminders. Healthcare providers can help patients manage their Hemophilia by viewing logs and receiving activity notifications. Q: How can Micro8 help your patients with Hemophilia A stay on track with their infusion schedule? A: Signing up for ...
hemophiliafirst.com
Products | Hemophilia First LLC
http://hemophiliafirst.com/products
Return to Top of Page. By: GriffinIX Media Web Design.
biogen.com
News & Insights
https://www.biogen.com/en_us/news-insights.html
Coagulation Factor IX [Recombinant], Fc Fusion Protein. Antihemophilic Factor [Recombinant], Fc Fusion Protein. Access to Investigational Therapies. Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases. Learn more about Biogen. See what we are working on. Access to Investigational Therapies.
biogen.com
Perspectives
https://www.biogen.com/en_us/news-insights/perspectives.html
Coagulation Factor IX [Recombinant], Fc Fusion Protein. Antihemophilic Factor [Recombinant], Fc Fusion Protein. Access to Investigational Therapies. Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases. Learn more about Biogen. See what we are working on. Access to Investigational Therapies.
biogen.com
Disclosure
https://www.biogen.com/en_us/medical-professionals/disclosure.html
Coagulation Factor IX [Recombinant], Fc Fusion Protein. Antihemophilic Factor [Recombinant], Fc Fusion Protein. Access to Investigational Therapies. Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases. Learn more about Biogen. See what we are working on. Access to Investigational Therapies.
biogen.com
Careers
https://www.biogen.com/en_us/careers.html
Coagulation Factor IX [Recombinant], Fc Fusion Protein. Antihemophilic Factor [Recombinant], Fc Fusion Protein. Access to Investigational Therapies. Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases. Learn more about Biogen. See what we are working on. Access to Investigational Therapies.
biogen.com
Investors
https://www.biogen.com/en_us/investors.html
Coagulation Factor IX [Recombinant], Fc Fusion Protein. Antihemophilic Factor [Recombinant], Fc Fusion Protein. Access to Investigational Therapies. Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases. Learn more about Biogen. See what we are working on. Access to Investigational Therapies.
biogen.com
Therapies
https://www.biogen.com/en_us/therapies.html
Coagulation Factor IX [Recombinant], Fc Fusion Protein. Antihemophilic Factor [Recombinant], Fc Fusion Protein. Access to Investigational Therapies. Biogen develops, manufactures and markets innovative therapies for patients living with serious neurological, autoimmune and rare diseases. At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases. Learn more about Biogen. See what we are working on. Access to Investigational Therapies.
SOCIAL ENGAGEMENT